NFKB1 and cardiovascular disorder: These compounds also inhibit nuclear factor-κB (NF-κB) activation, a key driver of pro-inflammatory cytokine production, thereby attenuating chronic low-grade inflammation implicated in cardiovascular diseases and neurodegenerative disorders [36].